Profit

Cipla Arm To Sell Stake In Four M Propack To Shriji Polymers

 Share
EMAIL
PRINT
COMMENTS
Cipla Arm To Sell Stake In Four M Propack To Shriji Polymers
New Delhi: Drug major Cipla on Wednesday said its subsidiary Goldencross Pharma has entered into a pact to sell its entire stake in Four M Propack to Shriji Polymers for a consideration of up to Rs 19.2 crore.

Goldencross Pharma Pvt Ltd, a wholly-owned subsidiary of the company, has entered into a definitive agreement to sell its 100 per cent equity stake in Four M Propack Ltd, India to Shriji Polymers India Ltd for a consideration of Rs 13.5 crore and an additional sum estimated at around Rs 5.7 crore, Cipla said in a filing to BSE.

The additional sum is derived on the basis of the value of mutual funds, cash and bank balance, tax refunds etc at the time of closing, it added.

"The transaction is expected to be completed within 45 days from the date of signing of the definitive agreement, subject to completion of certain condition precedent and receipt of applicable approvals," Cipla said.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)


Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Top